Ong G, Rasidah N, Wan S, Cutter J
Communicable Diseases Policy Branch, Communicable Diseases Division, Ministry of Health, College of Medicine Building, 16 College Road, Singapore 169854.
Singapore Med J. 2007 Jul;48(7):656-61.
Indigenous cases of measles continue to occur in Singapore despite the implementation of a two-dose mumps, measles and rubella (MMR) vaccination policy in 1998. We investigated a measles outbreak that took place in a primary school from April 17 to May 6, 2004 to identify all cases, evaluate vaccine efficacy (VE) and implement outbreak control measures.
A case of measles was defined as anyone having generalised rash and fever with or without cough, coryza or conjunctivitis during the outbreak period, and who had either laboratory-confirmed acute measles infection or was epidemiologically linked to a patient with laboratory-confirmed measles infection. Vaccination status was obtained from the studentos health booklet and confirmed with the National Immunisation Registry. Attack rates in unvaccinated (ARU) and vaccinated (ARV) students were calculated and VE was evaluated using the formula: VE (percent) = [(ARU-ARV) / ARU] x 100 percent.
Nine students, aged between eight and 14 years, from five classes in primary three and primary six, were epidemiologically linked to have measles. None of them had received the second dose of the MMR vaccine. 93 percent of students in the affected classes (n = 184) had prior documented evidence of receiving at least one dose of MMR vaccination, as compared to 96.5 percent for the entire school enrolment (n = 1,309). The attack rate was 1.2 percent in the vaccinated group and 53.8 percent in the unvaccinated group. The VE for the primary dose of MMR in the affected classes was 97.8 percent.
It is important to achieve a high coverage for the primary dose of MMR vaccine in order to prevent any potential outbreaks prior to receiving the booster dose.
尽管新加坡于1998年实施了两剂次腮腺炎、麻疹和风疹(MMR)疫苗接种政策,但本土麻疹病例仍时有发生。我们对2004年4月17日至5月6日在一所小学发生的麻疹疫情进行了调查,以确定所有病例、评估疫苗效力(VE)并实施疫情控制措施。
麻疹病例定义为在疫情期间出现全身性皮疹和发热,伴有或不伴有咳嗽、鼻炎或结膜炎,且实验室确诊为急性麻疹感染或在流行病学上与实验室确诊的麻疹感染患者有联系的任何人。疫苗接种状况从学生健康手册中获取,并通过国家免疫登记处进行确认。计算未接种疫苗(ARU)和接种疫苗(ARV)学生的发病率,并使用以下公式评估疫苗效力:疫苗效力(百分比)=[(ARU - ARV)/ ARU]×100%。
来自小学三年级和六年级五个班级的9名年龄在8至14岁之间的学生在流行病学上被证实感染了麻疹。他们均未接种第二剂MMR疫苗。受影响班级中93%的学生(n = 184)之前有记录证明至少接种过一剂MMR疫苗,而全校入学学生(n = 1309)的这一比例为96.5%。接种疫苗组的发病率为1.2%,未接种疫苗组为53.8%。受影响班级中MMR首剂疫苗的效力为97.8%。
实现MMR疫苗首剂的高接种覆盖率对于预防在接种加强剂之前的任何潜在疫情很重要。